NFAT5 and diabetic kidney disease: miR-486-5p also protects against ischemic kidney injury and targets PTEN [16, 45], associated with decreased expression of select genes involved in apoptosis and the TNF inflammatory pathway, and may confer a protective anti-fibrotic role in diabetic kidney disease by targeting NFAT5 [21].